Cargando…
Immune Checkpoints as a Target for Colorectal Cancer Treatment
Anti-tumor immunity is a new line of research for the treatment of patients with solid tumors. In this field, negative regulators of the immune system called immune checkpoints play a key role in limiting antitumor immunologic responses. For this reason, immune checkpoint-inhibiting agents, such as...
Autores principales: | Passardi, Alessandro, Canale, Matteo, Valgiusti, Martina, Ulivi, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486145/ https://www.ncbi.nlm.nih.gov/pubmed/28635639 http://dx.doi.org/10.3390/ijms18061324 |
Ejemplares similares
-
Circulating Plasma Levels of miR-20b, miR-29b and miR-155 as Predictors of Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer
por: Ulivi, Paola, et al.
Publicado: (2018) -
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
por: CHIADINI, ELISA, et al.
Publicado: (2015) -
Relationship between hypoxia and response to antiangiogenic therapy in metastatic colorectal cancer
por: Ulivi, Paola, et al.
Publicado: (2016) -
Metastatic Colorectal Cancer
por: Passardi, Alessandro, et al.
Publicado: (2021) -
Molecular and Translational Research on Colorectal Cancer
por: Passardi, Alessandro, et al.
Publicado: (2020)